UCLA Health

Researchers will look to identify genetic and environmental factors that determine how fast an individual’s Parkinson’s disease progresses.

The findings may help explain sex differences in heart disease and support the development of more personalized treatments.

The study's findings could ease concerns that the expansion of telemedicine would trigger spikes in usage and costs

At UCLA, Dr. David Nathanson is designing new therapies that tackle glioblastoma’s unique tumor biology, aiming to overcome long-standing treatment challenges.

The analysis of nearly 94,000 participants in UCLA’s ATLAS Biobank highlights the value of genetic diversity in developing precision health strategies.

The test could offer a more affordable approach to early disease detection.

A fruitful partnership between Charles R. Drew University and UCLA to train doctors for underserved communities enters a new era.

By equipping T cells with two proteins derived from fungi, the researchers enabled the immune cells to import cellobiose and convert it into usable glucose inside the cell.

Study identifies cellular defense system that protects neurons from toxic tau proteins, opening door to new treatments.

A novel shape of zinc oxide helps reduce chalkiness in mineral sunscreen and makes it easier to wear, especially for people with darker skin tones.

A new UCLA study combines human and animal research to identify chlorpyrifos as a potential environmental cause of brain disease.

Sedatives and antipsychotics linked to falls, confusion, and hospitalization remain widely used in patients most vulnerable to their harms.

The new grant will fund the enrollment of 10 additional patients in the trial and support research into the science behind immune tolerance.

The annual event underscored the university’s partnership with the VA and its commitment to helping service members.

Following the team’s discovery, researchers have identified a strategy to possibly prevent treatment relapses.

The findings point to a growing public health concern for younger Americans.

The findings mark the first time this regimen has demonstrated a survival benefit in the vast majority of patients with metastatic colorectal cancer.

Researchers say cell-free DNA can also distinguish between different neurological diseases.

Multiple subspecialties ranked in the U.S. News & World Report assessment.

Inhalers have generated over 2 million metric tons of carbon emissions annually over the past decade.

Dr. Beate Ritz’s research in California’s Central Valley highlights the role of the environment in the neurodegenerative disorder.

10 pediatric oncology patients at UCLA Health who were guests of Major League Baseball’s Childhood Cancer Awareness Night.

Recent headlines show how UCLA research findings and ongoing studies are making an impact across the nation and the globe.

An email to renowned autism investigator Dr. Daniel Geschwind is leading to new science.

The study found pembrolizumab shrank or eliminated tumors in nearly 90% of participants with desmoplastic melanoma that cannot be surgically removed.